VR Logo

Bionano Genomics Inc. (BNGO) download report


Healthcare | Diagnostics Services

Bionano Genomics Inc. (BNGO) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function.

IPO Date: 21-Aug-2018

Pres, CEO, Sec. & Director: Dr. Robert Erik Holmlin M.B.A., Ph.D.

Chief Operating Officer: Mr. Mark Oldakowski

Listing: NASDAQ: BNGO

Country: United States

Headquarters: San Diego, CA

Website: https://www.bionanogenomics.com

Key Facts

Market cap: $469.31 Mln

Revenue (TTM): $20.51 Mln

Earnings (TTM): $-92.44 Mln

Cash: $216.47 Mln

Total Debt: $11.12 Mln

Insider's Holding: 1.92%

Liquidity: Low

52 Week range: $1.16 - 7.84

Shares outstanding: 289,696,992

6 Years Aggregate:

  • CFO: $-204.03 Mln
  • EBITDA: $-182.03 Mln
  • Net Profit: $-204.07 Mln

Stock Performance

Time Period Bionano Genomics (BNGO) S&P BSE Sensex S&P Small-Cap 600
YTD-50.33-8.71-16.64
1 month-15.14-3.11-6.45
3 months-37.34-7.30-12.22
1 Year-80.250.48-15.87
3 Years-15.4910.347.51
5 Years--11.436.63
10 Years--12.1010.46
As on 28-Jun-2022
Year Bionano Genomics (BNGO) S&P Small-Cap 600 S&P BSE Sensex
2021-2.9225.2721.99
2020148.399.5715.75
2019-76.3420.8614.38